#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Post transplant lymphoproliferative disorder Raynaud's phenomenon Neuroblastoma Chondrosarcoma metastatic Wiskott-Aldrich syndrome Arterial disorder Prader-Willi syndrome T-cell type acute leukaemia Hereditary optic atrophy Nodal marginal zone B-cell lymphoma Rett syndrome Ventricular fibrillation Leiomyosarcoma recurrent Cytokine release syndrome Retinoblastoma More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent Turner’s syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information VEXAS syndrome – Life with Disease Fabry’s disease – Life with Disease Biotinidase deficiency – Life with Disease Chondrosarcoma metastatic – Diagnostics Lennox-Gastaut syndrome – Life with Disease Nephroblastoma – Basic Information Glycogen storage disease type II – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Keto-Valine Calcium Regn5668 Vancomycin Hydrochloride Ace Inhibitors, Plain Etifoxine Hydrochloride Formoterol Fumarate Goserelin Acetate Dobutamine Hydrochloride Latozinemab Mrna-3210 Simeticone M-(18F)-Fluorobenzylguanidine CICLOPIROX Calcium Chloride Hydroxypropyl Cellulose Lf Cabotegravir Sodium Oxazepam Fenofibrate L-Threonine Rebisufligene Etisparvovec More therapies…

    Learn about Your Condition

    Systemic sclerosis pulmonary Dysmenorrhoea Squamous cell carcinoma Incisional hernia Exfoliation glaucoma Kidney transplant rejection Gastrointestinal disorder Ligament sprain Wiskott-Aldrich syndrome Merycism Hodgkin's disease Lymphoedema Oesophageal adenocarcinoma Upper limb fracture Optic glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • Study on the Effectiveness and Safety of Eneboparatide in Patients with Chronic Hypoparathyroidism

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • Alfacalcidol
    • Calcitriol
    • Calcium Carbonate
    Spain

  • Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer
    Investigated Drugs:
    • Alpelisib
    • Gedatolisib
    • Palbociclib
    Austria Belgium Bulgaria Czechia France Germany +6

  • Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hot flush
    • Menopausal symptoms
    • Testosterone deficiency syndrome
    Investigated Drugs:
    • Elinzanetant
    Germany

  • A study to compare the absorption of testosterone transdermal gel in healthy female subjects

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hypogonadism male
    Investigated Drugs:
    • Testosterone
    Portugal

  • A study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • ALN-4324
    Germany Poland

  • Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • ALXN2420
    • Octreotide Acetate
    Denmark Hungary Italy Lithuania The Netherlands Poland +1
Previous Page
1 … 12 13 14 15 16 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!